K

Ketryx

SaaS platform for regulated medical software

Business Development Representative

Full-Time
$60k - $70k+ Uncapped commission + Equity options
Entry
Boston, MA, USA
In Person
Sales & Account ManagementSales Development Representative
No H1B Sponsorship

About the job

Requirements
  • Interest in building a career in sales.
  • Ability to grasp complex technical concepts quickly.
  • Ability to convey complex solutions clearly and compellingly.
  • A track record of meeting or exceeding targets.
  • Passion for healthcare technology and ability to connect with leaders in the medical device industry.
Responsibilities
  • Generate qualified sales demos and meetings.
  • Engage inbound and outbound leads through email, LinkedIn, and phone with tailored outreach.
  • Source opportunities with target accounts through cold emails and calls in collaboration with the marketing team and account-based marketing campaigns.
  • Participate in online conversations, including on LinkedIn, with interested people and target accounts.
  • Research inbound and outbound target people and companies.
  • Collaborate with the sales team to advance target accounts.
  • Develop a deep understanding of the product and target audiences.
  • Enter, update, and maintain customer relationship management information on leads throughout the funnel.
Desired Qualifications
  • Previous experience in enterprise sales, the medical device industry, or the healthcare industry is strongly preferred.

About the company

Ketryx offers a SaaS Connected Lifecycle Management platform for regulated medical software. It guides the full lifecycle from planning through verification and maintenance, ensuring compliance with FDA, IEC 62304, GMP, ISO 13485, and CFR 21 Part 11. The platform integrates traceability, documentation, Jira, and SBOM management to streamline development, quality, and compliance. It targets MedTech teams from startups to large enterprises, aiming to reduce compliance risk and development costs while speeding time to market.

Company Size

51-200

Company Stage

Series B

Total Funding

$57.1M

Headquarters

Cambridge, Massachusetts

Founded

2021

Get referred to Ketryx

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Ketryx raised $39 million on September 4, 2025, led by Transformation Capital.
  • Ketryx announced MCP beta on March 31, 2026, embedding compliance into AI workflows.
  • Four of five top Fortune 500 MedTech companies now run on Ketryx.

What critics are saying

  • FDA warning letters on AI usage in 2026 punish weak human oversight and validation.
  • Siemens Healthineers, Veeva, and Jama can bundle compliance into existing enterprise contracts.
  • If Ketryx loses trust in auditability, regulated buyers stop deployments immediately.

What makes Ketryx unique

  • Ketryx launched validated AI agents on May 1, 2025, for regulated medical workflows.
  • Ketryx holds ISO 13485, IEC 62304, ISO 27001, and SOC 2 Type II.
  • Ketryx serves Meta Reality Labs, Flo Health, DeepHealth, HeartFlow, and Fortune 500 MedTech.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options
  • Unlimited Paid Time Off
  • Stock Options

Growth & Insights and Company News

Headcount

6 month growth

2%

1 year growth

9%

2 year growth

7%
VentureFizz
Sep 30th, 2025
Hiring Unlocked: Ketryx Event Video - Company Details, Jobs, Culture, and More

Recently, Ketryx announced a $39M Series B round of funding led by Transformation Capital, with participation from existing investors including Lightspeed Venture Partners, MIT's E14 Fund, Ubiquity Ventures, and 53 Stations.

FinSMEs
Sep 4th, 2025
Ketryx Raises $39M in Series B Funding

Ketryx, a Cambridge, MA-based AI-powered compliance platform helping life sciences companies ship safer products faster, raised $39M in Series B funding

PR Newswire
Sep 4th, 2025
Ketryx Raises $39M Series B Round to Power the Future of Regulated Artificial Intelligence for Life Sciences

Ketryx raises $39M Series B round to power the future of regulated artificial intelligence for life sciences.

SiliconANGLE Media
Sep 4th, 2025
Ketryx raises $39M to help medical device makers ship safer products faster

Ketryx Corp., a company transforming product lifecycle development and compliance for medical device makers with artificial intelligence, today announced it has raised $39 million in a Series B funding round led by Transformation Capital.

TechIntelPro
May 2nd, 2025
Ketryx Launches First Validated AI Agents to Accelerate Safety-Critical Product Development

Ketryx launches first validated AI Agents to accelerate safety-critical product development.